Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2015 2
2016 2
2017 4
2018 5
2019 4
2020 7
2021 6
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial.
Toi M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, Mukai H, Saji S, Shimizu A, Ikeda T, Haga H, Saeki T, Aogi K, Sugie T, Ueno T, Kinoshita T, Kai Y, Kitada M, Sato Y, Jimbo K, Sato N, Ishiguro H, Takada M, Ohashi Y, Ohno S. Toi M, et al. Among authors: kai y. Lancet Oncol. 2021 Jan;22(1):74-84. doi: 10.1016/S1470-2045(20)30534-9. Lancet Oncol. 2021. PMID: 33387497 Clinical Trial.
Pulmonary enteric adenocarcinoma.
Handa Y, Kai Y, Ikeda T, Mukaida H, Egawa H, Kaneko M. Handa Y, et al. Among authors: kai y. Gen Thorac Cardiovasc Surg. 2016 Dec;64(12):749-751. doi: 10.1007/s11748-015-0569-0. Epub 2015 Jul 3. Gen Thorac Cardiovasc Surg. 2016. PMID: 26139021
Metachronous Lung Cancer After Pleurectomy/Decortication.
Kai Y, Tsutani Y, Ito M, Mimura T, Miyata Y, Okada M. Kai Y, et al. Ann Thorac Surg. 2019 Jan;107(1):e1-e3. doi: 10.1016/j.athoracsur.2018.05.087. Epub 2018 Jul 3. Ann Thorac Surg. 2019. PMID: 30558734
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer.
Masuda T, Ueo H, Okumura Y, Kai Y, Ando Y, Masuguchi K, Kitagawa M, Kitagawa A, Hayashi N, Tsuruda Y, Hisamatsu Y, Suehiro S, Ohmura H, Fujiyoshi K, Tanaka F, Mimori K. Masuda T, et al. Among authors: kai y. Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):182-194. doi: 10.21873/cgp.20373. Cancer Genomics Proteomics. 2023. PMID: 36870689 Free PMC article.
30 results